Mop-up via pre-IPO placements hits at least 6-year high, shows data

Amount close to Rs 1,000 crore in 2023; bankers say deals now happening closer to IPO price

IPO
Sundar Sethuraman Mumbai
4 min read Last Updated : Oct 06 2023 | 11:58 PM IST
Companies have raised nearly Rs 1,000 crore via pre-initial public offering (IPO) placements so far  this year — the highest amount since 2017, since when the data is available. 

Pre-IPO placements, typically conducted months before a maiden share sale, help establish a valuation base for an IPO and also instil confidence into investors about the company.

In the first nine months of 2023, 11 companies raised Rs 960 crore from pre-IPO placements, according to the data from Prime Database, a primary market data tracker. Some of the companies that sold shares through such placements this year include SBFC Finance (Rs 150 crore), Yatharth Hospital (Rs 120 crore), Jupiter Life Line (Rs 123 crore), and Cyient DLM (Rs 108 crore).

While anchor allotments are done only a day ahead of an IPO, a pre-IPO placement can happen anytime before the IPO and after the filing of the draft red-herring prospectus (DRHPs).

Also, pre-IPO shares can be allotted at any price, unlike anchor allotment, which can only be sold within the IPO price band. Investors subscribing to shares during pre-IPO placements must observe a six-month lock-in period post-listing.

“The quality of companies and limited allocation in anchor book has meant that more and more funds are opting for exposure through the pre-IPO route,” said Chirag Negandhi, joint managing director and co-CEO of Axis Capital.

Bankers said pre-IPO placements used to happen much earlier in the process, but now it’s closer to the IPO and done at or closer to the IPO price.


 
“Earlier, pre-IPO shares were sold at a discount because of a six-month lock-in. Now, they are look-ed at as a valuation benchmarking tool,” Pranjal Srivastava, partner - equity capital markets (ECM), Centrum Capital, said.

“There is some structural shift. Historically, pre-IPOs happened with a substantial gap from the IPO launch. Now, pre-IPOs are happening very close to IPOs. Companies are using pre-IPOs to establish valuation benchmarks and give markets the comfort that well-respected investors are comfortable with that kind of valuation,” said Munish Aggarwal, managing director (ECM), Equirus.

“In the past, pre-IPO rounds were done to fund business requirements in the run-up to the IPO. This is also reflected in pricing for pre-IPOs, wherein most transactions are happening at par with IPO pricing as compared to ‘discount to IPO pricing’ that was a norm in the past to accommodate higher perceived risk related to pricing and timing of IPO owing to a longer time gap between pre-IPO and IPO,” Aggarwal added.

The pick-up in pre-IPO deals seen this year is a sign of bullish sentiment, said market players. During the first half of 2023-24, 31 IPOs were launched, more than double compared to the same period of last year.

Market players said given the robust DRHP filings in recent months, pre-IPO deals would continue to gain momentum. In the past two months, over 30 companies filed their offer documents with market regulator Sebi. Many of these companies had a provision to allot shares via the pre-IPO route to investors. Also, some asset managers have launched alternative investment funds (AIFs) looking to invest in companies at the pre-IPOs stage. Such funds actively scout for pre-IP deals, say market players.


 
“There is confidence in companies as well as the IPO market. The trend is looking positive with many AIFs and other institutional investors participating and it is likely to continue," said Srivastava.

Negandhi said pre-IPO allotments would continue to remain a popular mechanism as many funds would look to buy at the pre-IPO stage, despite the post-listing lock-in requirements, fearing they may not get adequate allotments at the IPO stage.

However, some bankers feel market conditions will have a bearing on the popularity of this route.

“If there is a correction in the markets, the IPOs may still go through, but the issuers may have to sell the stake at a discount to the pre-IPO price,” said a banker requesting anonymity.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :IPOshare marketIndian stocksYatharth Hospital

Next Story